Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Discovery: Overview01:26

Drug Discovery: Overview

8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Prodrugs01:30

Prodrugs

3.0K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
3.0K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Goldilocks-Inspired Design of Mid-Size Macrocycles for Selective Targeting of Human Melanocortin Receptors.

Journal of medicinal chemistry·2026
Same author

Diverse ring architectures of cyclic peptidomimetics targeting melanocortin receptors.

RSC medicinal chemistry·2026
Same author

Exploiting a Cryptic Pocket in DsbA through Structure-Guided Parallel Synthesis and Direct-to-Biology Screening.

Journal of medicinal chemistry·2026
Same author

Electrochemical β-Lactam Probes for Rapid Detection of β-Lactamases: From Solution-Phase Activation toward Surface-Integrated Biosensing.

Journal of the American Chemical Society·2026
Same author

From lab to environment: forecasting pharmaceutical impact using <i>in silico</i> and analytical tools.

RSC medicinal chemistry·2026
Same author

Altered Glut4, IRAP, and Brain Insulin Signaling in a Mouse Model of Epilepsy and Contributions to Glucose Transport in Neurons and Astrocytes.

Journal of neurochemistry·2025

相关实验视频

Updated: May 6, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

10.9K

加速PROTAC药物发现的方法

Jeyan Osman1,2, Philip E Thompson1, Manuela Jörg1,3

  • 1Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.

The Biochemical journal
|June 26, 2025
PubMed
概括
此摘要是机器生成的。

向蛋白质分解的嵌合体 (PROTACs) 提供了一种新的方法来研究疾病和寻找药物. 本综述强调了加快PROTAC开发的关键策略,以改善药物发现.

关键词:
一个DNA编码的图书馆.然后点击化学.直接进入生物学.针对蛋白质溶解的嵌合体.固相合成的固相合成方法

更多相关视频

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.8K
A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
10:24

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources

Published on: January 27, 2026

594

相关实验视频

Last Updated: May 6, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

10.9K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.8K
A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
10:24

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources

Published on: January 27, 2026

594

科学领域:

  • 生物化学 生化学
  • 药用化学 医学化学
  • 药物发现 药物发现 药物发现

背景情况:

  • 化向化体 (PROTACs) 是一种新的治疗方式.
  • PROTACs利用细胞的无素-蛋白酶体系统进行向的蛋白质降解.
  • PROTACs的复杂性在其设计和合成方面带来了挑战.

研究的目的:

  • 审查加速PROTAC发展的关键领域.
  • 确定克服 PROTAC 设计和合成挑战的策略.
  • 为了提高基于PROTAC的药物发现计划的效率.

主要方法:

  • 专注于对蛋白质降解的适当目标选择.
  • 强调PROTACs的模块化化学合成方法.
  • 在PROTAC评估中使用高通量生物测试.

主要成果:

  • 简化了 PROTACs 的发展途径.
  • 在基于PROTAC的发现中成功率增加.
  • 促进对 PROTAC 机制和应用程序的理解.

结论:

  • 战略目标的选择,综合和评估对于 PROTAC 的进步至关重要.
  • 优化的方法可以加速新型PROTAC疗法的开发.
  • 对于未来的药物发现,PROTAC技术具有重大前景.